News and Stories
Therapeutic value of liver and pancreatic-targeted IL-22 in metabolic dysfunction-associated steatohepatitis (MASH) highlighted in this paper from the lab which is supported by Jetra Therapeutics, GESA and NHMRC
Our new paper in Nature Communications shows that IL-22RA1 (IL-22 receptor) endogenously in pancreatic beta-cells regulates insulin secretion, islet regeneration, inflammation/cellular stress and appropriate systemic metabolic regulation.
So excited to see this work out a collaborative effort with the Mark Schembri’s lab at The Institute of Molecular Biosciences at The University of Queensland.
Commentary on our work that shows for the first time a direct anti-inflammatory role for Interleukin-22.
This is how the HASNAIN LAB celebrates the end of a tough year.. Good riddance 2023!
Well done to PhD student Haressh Sajiir, who has won a travel sponsorship from Translational Research Institute, allowing him to present his work at the Keystone MASH and Fibrosis Conference!
Lab’s Xmas Day Out 2021
Bowling and Lunch
STEM in Schools
Speaking to Year 2 in schools about, how lungs, mucus and germs all come together
Mater Research Excellence Award 2021
Supported by The University of Queensland
Jetra Therapeutics
Our startup receives $1.3 Million in funds